Schedule 13G ownership disclosure

Apellis Pharmaceuticals Inc

Security class unavailable · CUSIP: 03753U106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,757,505
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000834237-20-004741
Form type
SC 13G/A
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Feb 05, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub